3.30 MB - Academy of Medicine of Malaysia
3.30 MB - Academy of Medicine of Malaysia
3.30 MB - Academy of Medicine of Malaysia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
MANAGEMENT OF HIV INFECTION IN CHILDREN<br />
207 Reddington C, Cohen J, Baldillo A et al. Adherence to medication regimens among<br />
children with human immunodeficiency virus infection. Pediatr Infect Dis J 2000; 19:1148-<br />
1153.<br />
208 Shelburne SA, Montes MM, Hamill RJ. Immune reconstitution inflammatory syndrome:<br />
more answers, more questions.J Antimicrob Chemother. 2006 Feb;57(2):167-170.<br />
209 Murdoch DM, Venter WD, Van Rie A et al. Immune reconstitution inflammatory syndrome<br />
(IRIS): review <strong>of</strong> common infectious manifestations and treatment options. AIDS Res Ther.<br />
2007 May 8;4:9.<br />
210 Puthanakit T, Oberdorfer P, Akarathum N, et al. Immune reconstitution syndrome after<br />
highly active antiretroviral therapy in human immunodeficiency virus-infected thai children.<br />
Pediatr Infect Dis J. 2006 Jan;25(1):53-58.<br />
211 Lee JC, Boechat MI, Belzer M, et al. Thymic volume, T-cell populations, and parameters<br />
<strong>of</strong> thymopoiesis in adolescent and adult survivors <strong>of</strong> HIV infection acquired in infancy.<br />
AIDS. 2006; 21:667-674.<br />
212 Flynn PM, Rudy BJ, Lindsey JC, et al. PACTG 381 Study Team. Long-term observation <strong>of</strong><br />
adolescents initiating HAART therapy: three-year follow-up. AIDS Res Hum Retroviruses.<br />
2007 Oct;23(10):1208-1214.<br />
213 Sharland M, Blanche S, Castelli G, et al. PENTA Steering Committee. PENTA guidelines<br />
for the use <strong>of</strong> antiretroviral therapy, 2004. HIV Med. 2004 Jul;5 Suppl 2:61-86.<br />
214 Machado DM, Fernandes SC, Freire WS, et al . Genotypic resistance pr<strong>of</strong>iles and<br />
subtypes <strong>of</strong> HIV-1 in brazilian children failing HAART. Int Conf AIDS. 2002 Jul 7-12; 14.<br />
215 Chaix ML, Rouet F, Kouakoussui K ,et al. Genotypic Human Immunodeficiency Virus type<br />
1 Drug Resistance in HAART treated children in Abidjan, Cote d’ Ivoire. Pediatr Infect Dis<br />
J .2005:24: 1072-1076.<br />
216 World Health Organization. HIV/AIDS Topics. Palliative Care.<br />
.<br />
217 World Health Organization. HIV/AIDS UNAIDS Publications. AIDS: Palliative Care<br />
http://data.unaids.org/Publications/IRC-pub05/jc453-pallicare-tu_en.pdf.<br />
218 M<strong>of</strong>enson LM, Oleske J, Serchuck L et al; CDC; National Institutes <strong>of</strong> Health; Infectious<br />
Diseases Society <strong>of</strong> America. Treating opportunistic infections among HIV-exposed and<br />
infected children: recommendations from CDC, the National Institutes <strong>of</strong> Health, and the<br />
Infectious Diseases Society <strong>of</strong> America. MMWR Recomm Rep. 2004 Dec 3;53(RR-14):<br />
1-92. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Aug 4;55(30):824.<br />
219 Gona P, Van Dyke RB, Williams PL et al. GR 3rd.Incidence <strong>of</strong> Opportunistic and Other<br />
Infections in HIV-Infected Children in the HAART Era JAMA. 2006 Jul 19;296(3):292-300.<br />
220 Ylitalo N, Brogly S, Hughes MD, et al. Risk factors for opportunistic illnesses in children<br />
with human immunodeficiency virus in the era <strong>of</strong> highly active antiretroviral therapy. Pediatr<br />
Adolesc Med. 2006 Aug;160(8):778-787.<br />
221 Pierre R, Steel-Duncan JC, Evans-Gilbert T, et al. CDC-defined diseases and opportunistic<br />
infections in Jamaican children with HIV/AIDS. West Indian Med J. 2004 Oct;53(5):<br />
315-321.<br />
67
Change language